Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

Published:2012-12 Issue:1 Volume:12 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Petrausch Ulf,Schuberth Petra C,Hagedorn Christian,Soltermann Alex,Tomaszek Sandra,Stahel Rolf,Weder Walter,Renner Christoph

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-12-615.pdf

Reference33 articles.

1. Robinson BW, Lake RA: Advances in malignant mesothelioma. N Engl J Med. 2005, 353 (15): 1591-1603. 10.1056/NEJMra050152.

2. Bianchi C, Bianchi T: Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007, 45 (3): 379-387. 10.2486/indhealth.45.379.

3. Fennell DA, Gaudino G, O'Byrne KJ, Mutti L, van Meerbeeck J: Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol. 2008, 5 (3): 136-147.

4. Opitz I, Kestenholz P, Lardinois D, Muller M, Rousson V, Schneiter D, Stahel R, Weder W: Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2006, 29 (4): 579-584. 10.1016/j.ejcts.2006.01.015.

5. Weder W, Opitz I, Stahel R: Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009, 21 (2): 172-176. 10.1053/j.semtcvs.2009.07.004.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors;Cancer Science;2024-08-21

2. CAR-T cell technologies that interact with the tumour microenvironment in solid tumours;Expert Review of Clinical Immunology;2024-07-17

3. Cardiac fibrogenesis: an immuno-metabolic perspective;Frontiers in Physiology;2024-03-21

4. Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications;Cancer Cell International;2024-03-12

5. CAR‐T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives;Cell Biochemistry and Function;2024-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3